Literature DB >> 19926131

Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-beta 1-40 peptide in mice.

Fabio Agostini Amaral1, Mayra Tolentino Resk Lemos, Karis Ester Dong, Maria Fernanda Queiroz Prado Bittencourt, Ariadiny Lima Caetano, João Bosco Pesquero, Tania Araujo Viel, Hudson Sousa Buck.   

Abstract

Chronic infusion of human amyloid-beta 1-40 (Abeta) in the lateral ventricle (LV) of rats is associated with memory impairment and increase of kinin receptors in cortical and hippocampal areas. Deletion of kinin B1 or B2 receptors abolished memory impairment caused by an acute single injection of Abeta in the LV. As brain tissue and kinin receptors could unlikely react to acute or chronic administration of a similar quantity of Abeta, we evaluated the participation of B1 or B2 receptors in memory impairment after chronic infusion of Abeta. Male C57Bl/6J (wt), knock-out B1 (koB1) or B2 (koB2) mice (12weeks of age) previously trained in a two-way shuttle-box and achieving conditioned avoidance responses (CAR, % of 50 trials) were infused with AB (550pmol, 0.12microL/h, 28days) or vehicle in the LV using a mini-osmotic pump. They were tested before the surgery (T0), 7 and 35days after the infusion started (T7; T35). In T0, no difference was observed between CAR of the control (Cwt=59.7+/-6.7%; CkoB1=46.7+/-4.0%; CkoB2=64.4+/-5.8%) and Abeta (Abetawt=66.0+/-3.0%; AbetakoB1=66.8+/-8.2%; AbetakoB2=58.7+/-5.9%) groups. In T7, AbetakoB2 showed a significant decrease in CAR (41.0+/-8.6%) compared to the control-koB2 (72.8+/-2.2%, P<0.05). In T35, a significant decrease (P<0.05) was observed in Abetawt (40.7+/-3.3%) and AbetakoB2 (41.2+/-10.7%) but not in the AbetakoB1 (64.0+/-14.0%) compared to their control groups. No changes were observed in the controls at T35. We suggest that in chronic infusion of BA, B1 receptors could play an important role in the neurodegenerative process. Conversely, the premature memory impairment of koB2 suggests that it may be a protective factor. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926131     DOI: 10.1016/j.npep.2009.10.006

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  α7 nicotinic ACh receptors are necessary for memory recovery and neuroprotection promoted by attention training in amyloid-β-infused mice.

Authors:  Milena Telles-Longui; Danilo Mourelle; Natalia Mendes Schöwe; Gabriela Cabett Cipolli; Helena Nascimento Malerba; Hudson Sousa Buck; Tania Araujo Viel
Journal:  Br J Pharmacol       Date:  2019-07-14       Impact factor: 8.739

2.  The bradykinin B1 receptor regulates Aβ deposition and neuroinflammation in Tg-SwDI mice.

Authors:  Giselle F Passos; Rodrigo Medeiros; David Cheng; Vitaly Vasilevko; Frank M Laferla; David H Cribbs
Journal:  Am J Pathol       Date:  2013-03-05       Impact factor: 4.307

3.  Dataset for the role of sustained attention in memory formation of transgenic mice for Alzheimer׳s disease.

Authors:  Natalia Mendes Schöwe; Eduardo Moreira de Oliveira; Hudson Sousa Buck; Tania Araujo Viel
Journal:  Data Brief       Date:  2016-01-16

4.  The Dual Role of Kinin/Kinin Receptors System in Alzheimer's Disease.

Authors:  Bingyuan Ji; Qinqin Wang; Qingjie Xue; Wenfu Li; Xuezhi Li; Yili Wu
Journal:  Front Mol Neurosci       Date:  2019-10-01       Impact factor: 5.639

5.  Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity.

Authors:  Carla Petrella; Maria Teresa Ciotti; Robert Nisticò; Sonia Piccinin; Pietro Calissano; Simona Capsoni; Delio Mercanti; Sebastiano Cavallaro; Roberta Possenti; Cinzia Severini
Journal:  Cells       Date:  2020-12-10       Impact factor: 6.600

6.  Normal cognition in transgenic BRI2-Aβ mice.

Authors:  Jungsu Kim; Paramita Chakrabarty; Amanda Hanna; Amelia March; Dennis W Dickson; David R Borchelt; Todd Golde; Christopher Janus
Journal:  Mol Neurodegener       Date:  2013-05-12       Impact factor: 14.195

7.  Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Marielza Andrade Nunes; Natalia Mendes Schöwe; Karla Cristina Monteiro-Silva; Ticiana Baraldi-Tornisielo; Suzzanna Ingryd Gonçalves Souza; Janaina Balthazar; Marilia Silva Albuquerque; Ariadiny Lima Caetano; Tania Araujo Viel; Hudson Sousa Buck
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

8.  Neuroprotective Effects of Pomegranate Peel Extract after Chronic Infusion with Amyloid-β Peptide in Mice.

Authors:  Maressa Caldeira Morzelle; Jocelem Mastrodi Salgado; Milena Telles; Danilo Mourelle; Patricia Bachiega; Hudson Sousa Buck; Tania Araujo Viel
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.